1. Home
  2. CLBK vs DAWN Comparison

CLBK vs DAWN Comparison

Compare CLBK & DAWN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CLBK
  • DAWN
  • Stock Information
  • Founded
  • CLBK 1927
  • DAWN 2018
  • Country
  • CLBK United States
  • DAWN United States
  • Employees
  • CLBK N/A
  • DAWN N/A
  • Industry
  • CLBK Savings Institutions
  • DAWN Biotechnology: Pharmaceutical Preparations
  • Sector
  • CLBK Finance
  • DAWN Health Care
  • Exchange
  • CLBK Nasdaq
  • DAWN Nasdaq
  • Market Cap
  • CLBK 1.5B
  • DAWN 1.3B
  • IPO Year
  • CLBK N/A
  • DAWN 2021
  • Fundamental
  • Price
  • CLBK $16.00
  • DAWN $12.54
  • Analyst Decision
  • CLBK Hold
  • DAWN Strong Buy
  • Analyst Count
  • CLBK 1
  • DAWN 7
  • Target Price
  • CLBK $17.00
  • DAWN $36.33
  • AVG Volume (30 Days)
  • CLBK 84.8K
  • DAWN 1.2M
  • Earning Date
  • CLBK 01-27-2025
  • DAWN 02-24-2025
  • Dividend Yield
  • CLBK N/A
  • DAWN N/A
  • EPS Growth
  • CLBK N/A
  • DAWN N/A
  • EPS
  • CLBK 0.15
  • DAWN N/A
  • Revenue
  • CLBK $201,023,000.00
  • DAWN $101,953,000.00
  • Revenue This Year
  • CLBK N/A
  • DAWN N/A
  • Revenue Next Year
  • CLBK $19.06
  • DAWN $35.22
  • P/E Ratio
  • CLBK $106.95
  • DAWN N/A
  • Revenue Growth
  • CLBK N/A
  • DAWN N/A
  • 52 Week Low
  • CLBK $13.79
  • DAWN $11.13
  • 52 Week High
  • CLBK $20.46
  • DAWN $18.07
  • Technical
  • Relative Strength Index (RSI)
  • CLBK 47.70
  • DAWN 49.68
  • Support Level
  • CLBK $15.70
  • DAWN $11.13
  • Resistance Level
  • CLBK $16.23
  • DAWN $13.30
  • Average True Range (ATR)
  • CLBK 0.38
  • DAWN 0.51
  • MACD
  • CLBK 0.11
  • DAWN 0.05
  • Stochastic Oscillator
  • CLBK 84.56
  • DAWN 64.98

About CLBK Columbia Financial Inc.

Columbia Financial Inc is a federally chartered savings bank that serves the financial needs of depositors and the local community as a community-minded, customer service-focused institution. It offers traditional financial services to businesses and consumers. It attracts deposits from the general public and uses those funds to originate a variety of loans, including multifamily and commercial real estate loans, commercial business loans, one-to-four family real estate loans, construction loans, home equity loans and advances, and other consumer loans, and also offers a broad range of insurance products, investment solutions, and wealth management services.

About DAWN Day One Biopharmaceuticals Inc.

Day One Biopharmaceuticals Inc is a clinical-stage biopharmaceutical company. It is dedicated towards developing and commercializing targeted therapies for patients of all ages with genetically defined cancers. Initially, it focuses on clinical development efforts on pediatric patients living with cancer, a vulnerable population that has been underserved in the recent revolution in targeted therapeutics and immuno-oncology. The product candidate, DAY101, is an oral, brain-penetrant, highly-selective type II pan-rapidly accelerated fibrosarcoma, or pan-RAF, kinase inhibitor.

Share on Social Networks: